From: Role of KIR and CD16A genotypes in colorectal carcinoma genetic risk and clinical stage
CD16A Haplotype | LCTR HF (n = 61) | CRC HF (n = 52) | p valueb | Grade I–IIa (n = 31) (af %) | P valueb | Grade III–IVa(n = 19) (af %) | p valueb |
---|---|---|---|---|---|---|---|
48T-158G (48L158 V) | 0.42623 ± 0.045824 | 0.432692 ± 0.049342 | NS | 45.2 | NS | 36.8 | NS |
48T-158T (48L158F) | 0.409836 ± 0.047115 | 0.384615 ± 0.047437 | NS | 38.7 | NS | 39.5 | NS |
48A-158G (48H158 V) | 0.049180 ± 0.01791 | 0.12500 ± 0.033282 | 0.05^ | 11.3 | NS | 15.8 | 0.037§ |
48G-158G (48R158 V) | 0.114754 ± 0.026747 | 0.057692 ± 0.02222 | NS | 4.8 | NS | 7.9 | NS |